IP Library Granted Patent US 12,419,988
Granted Patent B2
US 12,419,988 · App. 17/063,484 · Granted Sep 23, 2025

Medical device, method of using and making the same

Inventor: Norman C. Furbush (Elm City, NC)
A61L15/425A61L15/22A61L15/52A61L15/54A61L2300/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,988
App. No.
17/063,484
Granted
Sep 23, 2025
Kind
B2
Abstract

The invention is directed towards a device, method of using and making the same and more particularly to a sterile, biocompatible, fiber free, foam device configured to be used in various different uses, e.g., medical uses, make-up removal uses, and other uses.

Claims (28)

1. A biocompatible reusable medical device, comprising:

a cellulose free laundered hydrophilic foam material, wherein the cellulose free laundered hydrophilic foam material is laundered in an aqueous solution of low particulate water to reduce manufacturing particulates such that the cellulose free laundered hydrophilic foam material has less than 10,000 particles/cm 2 ≥5 μm, and the cellulose free laundered hydrophilic foam material has a shape having an x-dimension, y-dimension and z-dimension, wherein the cellulose free laundered hydrophilic foam material comprises an open celled reticulated foam material extending without voids throughout an internal body region of the x-dimension, y-dimension and z-dimension, wherein the cellulose free laundered hydrophilic foam material comprises a latex free material, a bisphenol A (BPA) free material, and a di(2-ethylhexyl) phthalate (DEHP) free material; and

a plurality of spaced apart scratch resistant radiopaque ink imaging markers adhered directly on an outer surface of the open celled reticulated foam material, wherein the plurality of spaced apart scratch resistant radiopaque ink imaging markers are configured in a pattern and configured to be visible with an external imagining device at various different orientations of the biocompatible reusable medical device.

2. The biocompatible reusable medical device of claim 1 , wherein the cellulose free laundered hydrophilic foam material comprises a color.

3. The biocompatible reusable medical device of claim 1 , wherein the cellulose free laundered hydrophilic foam material is laundered in the aqueous solution and has a bacterial endotoxicity level below about 7.0 EU/device.

4. The biocompatible reusable medical device of claim 1 , wherein the pattern comprises a grid pattern.

5. The biocompatible reusable medical device of claim 1 , wherein the cellulose free laundered hydrophilic foam material comprises a bacterial endotoxin less than 20.00 EU/device.

6. The biocompatible reusable medical device of claim 1 , wherein the cellulose free laundered hydrophilic foam material is non-cytotoxic.

7. The biocompatible reusable medical device of claim 1 , wherein each of the plurality of spaced apart scratch resistant radiopaque ink imaging markers are arranged in a circular shape and have a diameter in a range from about 0.5 mm to about 10 mm.

8. The biocompatible reusable medical device of claim 1 , wherein the pattern comprises a geometric pattern.

9. A biocompatible reusable surgical medical device, comprising:

a hydrophilic foam material laundered in an aqueous solution of low particulate water to reduce manufacturing particulates, the hydrophilic foam material has less than 10,000 particles/cm 2 ≥5 μm, and having a continuous voidless body region, a top surface, a bottom surface, and side surfaces, wherein the continuous voidless body region comprises an open celled structure, wherein the hydrophilic foam material comprises a cellulose free material, a latex free material, a bisphenol A (BPA) free material, and di(2-ethylhexyl) phthalate (DEHP) free material; and

a plurality of scratch resistant radiopaque ink dot imaging markers formed in a grid pattern directly on the top surface, wherein the plurality of scratch resistant radiopaque ink dot imaging markers are configured to be visible with external imaging and each of the plurality of scratch resistant radiopaque ink dot imaging markers are spaced apart from each other, and

wherein the biocompatible reusable surgical medical device is configured to be reused during a medical procedure.

10. The biocompatible reusable surgical medical device of claim 9 , wherein the external imaging is one of x-ray imaging and ultrasound imaging.

11. The biocompatible reusable surgical medical device of claim 9 , wherein each of the plurality of scratch resistant radiopaque ink dot imaging markers are arranged in a circular shape and have a diameter in a range from about 0.5 mm to about 10 mm.

12. The biocompatible reusable surgical medical device of claim 9 , wherein the hydrophilic foam material comprises a color.

13. The biocompatible reusable surgical medical device of claim 9 , wherein the hydrophilic foam material is sized to fit within a lumen of a trocar.

14. The biocompatible reusable surgical medical device of claim 9 , wherein the hydrophilic foam material is configured to be hydrated within a sterile fluid.

15. A biocompatible reusable multi-use surgical medical device for repeated use during a medical procedure, comprising:

a laundered flexible hydrophilic foam material having a top surface, a bottom surface, and side surfaces, wherein the laundered flexible hydrophilic foam material includes a continuous open celled structure extending without voids throughout the entire flexible hydrophilic foam material, wherein the laundered flexible hydrophilic foam material is configured to be foldable into various shapes and sizes during a medical procedure, wherein the laundered flexible hydrophilic foam material is laundered in an aqueous solution of low particulate water to reduce manufacturing particulates, the laundered flexible hydrophilic foam material has less than 10,000 particles/cm 2 ≥5 μm, and, wherein the laundered flexible hydrophilic foam material comprises a cellulose free material, a latex free material, a bisphenol A (BPA) free material, and a di(2-ethylhexyl) phthalate (DEHP) free material; and

a plurality of spaced apart scratch resistant radiopaque ink imaging markers arranged in a grid pattern directly on the top surface of the laundered flexible hydrophilic foam material, wherein at least a portion of the plurality of spaced apart scratch resistant radiopaque ink imaging markers are configured to be visible with external imaging at different spatial orientations and each of the plurality of spaced apart scratch resistant radiopaque ink imaging markers have a width in a range from about 0.5 mm to about 2 mm.

16. The biocompatible reusable multi-use surgical medical device of claim 15 , wherein the laundered flexible hydrophilic foam material comprises a color.

17. The biocompatible reusable multi-use surgical medical device of claim 15 , wherein the laundered flexible hydrophilic foam material is sized to fit within a lumen of a trocar.

18. The biocompatible reusable multi-use surgical medical device of claim 15 , wherein the laundered flexible hydrophilic foam material is configured to be hydrated with a sterile fluid and configured to be wrung out to remove at least some of the sterile fluid, and configured to be wrung out with the sterile fluid during the medical procedure to remove at least some blood and bodily fluids it may have absorbed and configured to be reused to absorb additional blood and bodily fluids.

19. The biocompatible reusable multi-use surgical medical device of claim 15 , wherein the laundered flexible hydrophilic foam material comprises a bacterial endotoxin less than 20.00 EU/device.

20. The biocompatible reusable medical device of claim 1 , wherein the cellulose free laundered hydrophilic foam material is configured to be hydrated with a sterile fluid and configured to be wrung out to remove at least some of the sterile fluid, and configured to be wrung out with the sterile fluid during a medical procedure to remove at least some blood or bodily fluids it may have absorbed and configured to be reused to absorb additional blood or bodily fluids during the medical procedure.

21. The biocompatible reusable surgical medical device of claim 9 , wherein the hydrophilic foam material is configured to be hydrated with a sterile fluid and configured to be wrung out to remove at least some of the sterile fluid, and configured to be wrung out with the sterile fluid during the medical procedure to remove at least some blood or bodily fluids it may have absorbed and configured to be reused to absorb additional blood or bodily fluids during the medical procedure.

Continuity (2)
Provisional Application 62909895 · Oct 3, 2019
Related Publication 20210100926A1 · Apr 8, 2021
References Cited (82)
US 727146A · Johnson · 1903 [cited by applicant]
US D181367S · Moroni · 1957 [cited by applicant]
US 3566871A · Richter · 1971 [cited by examiner]
US 3678933A · Moore et al. · 1972 [cited by applicant]
US 3949742A · Nowakowski · 1976 [cited by applicant]
US 3961629A · Richter et al. · 1976 [cited by applicant]
US 4193405A · Abels · 1980 [cited by applicant]
US D261936S · Sumiyasu · 1981 [cited by applicant]
US D268208S · Brown et al. · 1983 [cited by applicant]
US 4626251A · Shen · 1986 [cited by applicant]
US D297461S · Inoue et al. · 1988 [cited by applicant]
US D313651S · Michelson et al. · 1991 [cited by applicant]
US 5010902A · Rambo et al. · 1991 [cited by applicant]
US 5274874A · Cercone et al. · 1994 [cited by applicant]
US 5447505A · Valentine et al. · 1995 [cited by applicant]
US 5556391A · Cercone et al. · 1996 [cited by applicant]
US D375816S · Long-Langworthy et al. · 1996 [cited by applicant]
US 5584386A · Ahonen · 1996 [cited by applicant]
US D382343S · Wandell et al. · 1997 [cited by applicant]
US D389581S · Fein et al. · 1998 [cited by applicant]
US 6004640A · Pisacane · 1999 [cited by examiner]
US D439982S · Ruscitti · 2001 [cited by applicant]
US 6613347B2 · Drury · 2003 [cited by applicant]
US D504540S · Bailey · 2005 [cited by applicant]
US D637501S · Begin et al. · 2011 [cited by applicant]
US D658769S · Moser et al. · 2012 [cited by applicant]
US D709205S · Ehninger et al. · 2014 [cited by applicant]
US D723701S · Maki et al. · 2015 [cited by applicant]
US D806256S · Allen et al. · 2017 [cited by applicant]
US 10201457B2 · Maharaj et al. · 2019 [cited by applicant]
US D858778S · Foley et al. · 2019 [cited by applicant]
US D876647S · Lin · 2020 [cited by applicant]
US D946765S · Chen et al. · 2022 [cited by applicant]
US D957671S · Kiviat · 2022 [cited by applicant]
US D964572S · Kase · 2022 [cited by applicant]
US D983380S · Lear et al. · 2023 [cited by applicant]
US D991463S · Sepulveda · 2023 [cited by applicant]
US D1008661S · Lehtonen · 2023 [cited by applicant]
US 11844675B1 · Hoeprich et al. · 2023 [cited by applicant]
US D1028254S · Li · 2024 [cited by applicant]
US D1028255S · Zhang · 2024 [cited by applicant]
US 20010022063A1 · Korteweg · 2001 [cited by examiner]
US 20030130576A1 · Seeley · 2003 [cited by examiner]
US 20070010844A1 · Gong · 2007 [cited by examiner]
US 20080015484A1 · Wolfensberger · 2008 [cited by applicant]
US 20080177240A1 · Kemnitzer, II · 2008 [cited by examiner]
US 20090099082A1 · Schoenberger · 2009 [cited by examiner]
US 20090264990A1 · Bruszewski · 2009 [cited by examiner]
US 20130035655A1 · Nakamura · 2013 [cited by applicant]
US 20130079590A1 · Bengtson · 2013 [cited by applicant]
US 20140171739A1 · Nguyen · 2014 [cited by examiner]
US 20140295134A1 · Wood et al. · 2014 [cited by applicant]
US 20150182657A1 · Rieske et al. · 2015 [cited by applicant]
US 20180344429A1 · Stewart · 2018 [cited by applicant]
US 20190117464A1 · Seo et al. · 2019 [cited by applicant]
US 20200390848A1 · Nair · 2020 [cited by applicant]
US 20210338490A1 · Kieswetter · 2021 [cited by examiner]
US 20220403590A1 · Yamashita · 2022 [cited by applicant]
EM EU0091770250001 · 2022 [cited by applicant]
EM EU0091770250002 · 2022 [cited by applicant]
GB 1195623A · 1970 [cited by applicant]
JP 2013538629A · 2013 [cited by examiner]
WO WO2011014907A1 · 2011 [cited by examiner]
WO WO2012129270A1 · 2012 [cited by examiner]
WO WO2019042790A1 · 2019 [cited by examiner]
Translation of JP-2013538629-A (Year: 2013). [cited by examiner]
Creative Materials, 125-09TS Radio Opaque Ink, Nov. 29, 2017. (Year: 2017). [cited by examiner]
International Search report and Written Opinion issued in International Application No. PCT/US2020/054293, mailed on Feb. 12, 2021, 13 pages. [cited by applicant]
International Preliminary Report issued in International Application No. PCT/US2020/054293, mailed on Apr. 5, 2022, 9 pages. [cited by applicant]
Extended European Search Report issued in European Application No. 20872988.9, mailed on Oct. 6, 2023, 10 pages. [cited by applicant]
Amazon, “80-20 Inc 3 Hole Straight Flat Plate,” Apr. 11, 2014, [Retrieved on Jun. 25, 2024], 2 Pages, Retrieved from the Internet URL: https://www.amazon.com/80-20-30-4306-3-Hole-Joining/dp/BOOJMEMOE4. [cited by applicant]
Amazon, “80-20 Inc 4 Hole Straight Flat Plate,” Jan. 16, 2018, [Retrieved on Jun. 25, 2024], 2 Pages, Retrieved from the Internet URL: https://www.amazon.com/dp/B0792BFSHR. [cited by applicant]
Amazon, “Allaquix High Performance Stop Bleeding Gauze,” Jan. 4, 2017, [Retrieved on Jun. 25, 2024], 4 Pages, Retrieved from the Internet URL: https://www.amazon.com/AllaQuix-Bleeding-Professional-Grade-First-Aid-Hemost… [cited by applicant]
Amazon, “Impresa White Liposuction Foam Pads,” Apr. 10, 2019, [Retrieved on Jun. 25, 2024], 3 Pages, Retrieved from the Internet URL: https://www.amazon.com/Pack-Lipo-Foam-Liposuction-Compression/dp/B07QH7X659. [cited by applicant]
Medicalmonks, “Surgifoam Absorbable Gelatin Sponge,” Sep. 8, 2021, [Retrieved on Jun. 25, 2024], 2 Pages, Retrieved from the Internet URL: https://medicalmonks.com/product/surgifoam-absorbable-gelatin-sponge/. [cited by applicant]
NHS, “Mallet Finger,” esht.nhs.uk, Sep. 8, 2023, [Retrieved on Jun. 25, 2024], 4 Pages, Retrieved from the Internet URL: https://www.esht.nhs.uk/wp-content/uploads/2017/06/0167.pdf. [cited by applicant]
Ormanagement, “Alloderm Regenerative Tissue Matrix,” [Retrieved on Jun. 25, 2024], 1 Page, Retrieved from the Internet URL: https:// www.ormanagement.net/BuyersGuide/ProductView?id=1592. [cited by applicant]
Sntervention, “Swicker Radiopaque Surgical Foam Brochure,” 2023, [Retrieved on Jun. 25, 2024], 2 Pages, Retrieved from the Internet URL: https://syntervention.com/wp-content/uploads/2024/01/LB3051-REV-01-SWICKER-brochur… [cited by applicant]
Syntervention, “Swicker Radiopaque Surgical Foam Sponge,” May 16, 2022, [Retrieved on Jun. 25, 2024], 6 pages, Retrieved from the Internet URL: https://syntervention.com/swicker/ (Year: 2022). [cited by applicant]
Syntervention, “Swicker Surgical Sponge Overview,” Youtube, Sep. 8, 2023, 2 Pages, Retrieved from the Internet URL: https://www.youtube.com/watch?v=dj8QXOOKUel. [cited by applicant]
Syntervention “Swiper Instructions for Use,” Youtube, Feb. 6, 2014, 2 Pages, Retrieved from the Internet URL: https://www.youtube.com/watch?v=Q5gnnifYoeU. [cited by applicant]
WFLA, “New Surgical Foam Technology Offers Significant Benefits to Hospitals As Alternative to Conventional Surgical Products,” Jun. 5, 2024, [Retrieved on Jun. 25, 2024], 4 Pages, Retrieved from the Internet URL: https… [cited by applicant]